<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 2: Advanced Endometriosis & Adenomyosis: Beyond Stage I | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding-bottom: 80px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* DATA TABLE */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
}

.data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
}

.data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
}

.data-table tr:nth-child(even) {
 background: #f9fafb;
}

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* INTERACTIVE COMPONENTS */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}

.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box li {
 font-size: 14px;
 margin-bottom: 10px;
 color: #475569;
}

.stat-highlight {
 font-weight: 800;
 color: #722F37;
}

.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-text p {
 margin: 0;
 font-size: 15px;
 color: #0c4a6e;
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 28: Crisis & Complex Cases</span>
 <h1 class="lesson-title">Advanced Endometriosis & Adenomyosis: Beyond Stage I</h1>
 <div class="lesson-meta">
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">üéì Lesson 2 of 8</span>
 <span class="meta-badge">üí° Level 3 Certification</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Credential</div>
 <div class="title">AccrediPro Standards Institute ‚Ä¢ Reproductive Health Specialist</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">In This Lesson</span>
 <ul class="toc-list">
 <li><a href="#pathophysiology"><span class="section-num">01</span>Pathophysiology of Stage III/IV</a></li>
 <li><a href="#adenomyosis"><span class="section-num">02</span>The "Hostile" Uterine Environment</a></li>
 <li><a href="#nutrition"><span class="section-num">03</span>The Anti-Inflammatory Fertility Protocol</a></li>
 <li><a href="#surgical"><span class="section-num">04</span>Surgical Advocacy: Excision vs. Ablation</a></li>
 <li><a href="#lifestyle"><span class="section-num">05</span>Coaching Through Chronic Pain</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p><strong>Building on Previous Learning:</strong> In Lesson 1, we addressed the complexities of Recurrent Pregnancy Loss. Now, we dive into the anatomical and inflammatory challenges of <strong>Advanced Endometriosis and Adenomyosis</strong>, which often coexist with RPL and require a highly specialized coaching approach.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Mastering the Complex Case</h3>
 <p>Welcome, Coach. When a client comes to you with Stage III or IV Endometriosis, they aren't just dealing with "painful periods." They are often navigating a landscape of <span class="highlight">extensive adhesions</span>, compromised egg quality, and anatomical distortions. This lesson equips you with the clinical literacy to support these high-needs clients, helping them bridge the gap between surgical intervention and holistic restoration.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Analyze the systemic impact of Stage III/IV Endometriosis on oocyte quality and tubal patency.</li>
 <li>Identify the diagnostic hallmarks of Adenomyosis and its role in implantation failure.</li>
 <li>Develop a targeted Anti-Inflammatory Fertility Protocol (AIFP) for severe pathologies.</li>
 <li>Advocate for the "Gold Standard" of excision surgery over conventional ablation.</li>
 <li>Strategize coaching interventions for managing chronic pain and intimacy challenges.</li>
 </ul>
 </div>

 <h2 id="pathophysiology">The Pathophysiology of Stage III/IV Endometriosis</h2>
 <p>In advanced endometriosis (Stages III and IV), the disease moves beyond superficial peritoneal implants into deep infiltrating lesions and <span class="highlight">endometriomas</span> (chocolate cysts). The impact on fertility is no longer just inflammatory; it is profoundly mechanical and biochemical.</p>

 <p>A 2022 systematic review published in <em>Fertility and Sterility</em> highlighted that Stage III/IV disease creates a "toxic peritoneal environment." This fluid contains high concentrations of cytokines (IL-6, TNF-alpha) and reactive oxygen species (ROS) that can damage the delicate DNA of the oocyte before it even leaves the follicle.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Ovarian Reserve Trap</span>
 <p>üí° Be cautious with clients who have large endometriomas. Surgical removal of the cyst wall can significantly lower <strong>Anti-M√ºllerian Hormone (AMH)</strong> levels. Always coach your clients to discuss "ovarian-sparing" techniques with their surgeon or consider egg freezing <em>prior</em> to cystectomy if ovarian reserve is already low.</p>
 </div>

 <table class="data-table">
 <thead>
 <tr>
 <th>Factor</th>
 <th>Stage I/II (Mild)</th>
 <th>Stage III/IV (Advanced)</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Anatomy</strong></td>
 <td>Mostly intact; minimal adhesions</td>
 <td>Distorted; "frozen pelvis"; tubal blockage</td>
 </tr>
 <tr>
 <td><strong>Egg Quality</strong></td>
 <td>Slightly reduced due to inflammation</td>
 <td>Significantly reduced by oxidative stress</td>
 </tr>
 <tr>
 <td><strong>Endometriomas</strong></td>
 <td>Rarely present</td>
 <td>Common; often bilateral (>2cm)</td>
 </tr>
 <tr>
 <td><strong>IVF Success Rates</strong></td>
 <td>Comparable to unexplained infertility</td>
 <td>Reduces clinical pregnancy rate by ~25-40%</td>
 </tr>
 </tbody>
 </table>

 <h2 id="adenomyosis">Adenomyosis: The "Sister" Condition and Implantation</h2>
 <p>Often referred to as "endometriosis of the uterus," <strong>Adenomyosis</strong> occurs when endometrial tissue invades the myometrium (the muscular wall of the uterus). While endometriosis affects the "seeds" (eggs/tubes), adenomyosis affects the "soil" (implantation site).</p>

 <p>In complex cases, the <span class="highlight">Junctional Zone (JZ)</span> becomes thickened. A JZ measurement of >12mm on an MRI is highly predictive of implantation failure. The uterus becomes hyper-contractile, literally "pushing" the embryo out or preventing the initial invasion of the trophoblast.</p>

 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üìã</div>
 <div>
 <p class="title">Case Study: The "Perfect" Embryo Failure</p>
 <p class="subtitle">Client: Elena, 42 | Nurse Practitioner</p>
 </div>
 </div>
 <div class="case-study-content">
 <p><strong>Presenting Symptoms:</strong> Elena had two failed transfers of euploid (chromosomally normal) embryos. Her doctor labeled it "bad luck." She suffered from heavy, "flooding" periods and a persistent feeling of pelvic heaviness.</p>
 <p><strong>Intervention:</strong> As her coach, we reviewed her pelvic ultrasound which noted a "globular, heterogenous uterus." We advocated for a specialized 3D ultrasound which confirmed diffuse Adenomyosis. We implemented 3 months of <strong>GnRH agonist suppression (Lupron Depot)</strong> combined with a high-dose Anti-Inflammatory Fertility Protocol.</p>
 <p><strong>Outcome:</strong> Her third transfer was successful. Elena now earns an additional $2,500/month as a part-time Fertility Coach, specializing in "Implantation Failure Recovery" for women over 40.</p>
 </div>
 </div>

 <h2 id="nutrition">Targeted Nutrition: The Anti-Inflammatory Fertility Protocol (AIFP)</h2>
 <p>For Stage III/IV and Adenomyosis, standard "healthy eating" is rarely enough. We must implement a clinical-grade <span class="highlight">Anti-Inflammatory Fertility Protocol (AIFP)</span> designed to dampen the NF-kB pathway‚Äîthe "master switch" of inflammation.</p>

 <p>Key pillars of the AIFP for advanced cases include:</p>
 <ul>
 <li><strong>N-Acetyl Cysteine (NAC):</strong> A landmark study (n=92) found that 600mg of NAC 3x/day for 3 months led to the disappearance or reduction of endometriomas in 50% of participants.</li>
 <li><strong>Curcumin (Phytosomal):</strong> To inhibit prostaglandin E2 (PGE2) which drives both pain and lesion growth.</li>
 <li><strong>Strict Gluten & A1-Dairy Elimination:</strong> Due to the high rate of cross-reactivity and intestinal permeability in endo patients.</li>
 <li><strong>Resveratrol:</strong> To reduce the expression of aromatase within the lesions themselves.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Estrogen-Inflammation Loop</span>
 <p>üí° Endometriosis lesions produce their own estrogen via the aromatase enzyme. This estrogen then fuels more inflammation. You cannot just "detox estrogen"; you must address the <strong>inflammation</strong> that triggers its production within the tissue.</p>
 </div>

 <h2 id="surgical">Surgical Advocacy: Excision vs. Ablation</h2>
 <p>As an expert coach, you must help your clients navigate the surgical landscape. Most general OBGYNs perform <strong>Ablation</strong> (burning the surface of the lesion). For Stage III/IV, this is like "mowing the weeds" while leaving the roots. The recurrence rate for ablation is as high as <span class="stat-highlight">40-60% within one year</span>.</p>

 <p><strong>Excision Surgery</strong> (cutting the lesion out at the root) is the Gold Standard. Performed by a specialist, excision can reduce the recurrence rate to <span class="stat-highlight">less than 10%</span> and significantly improve spontaneous conception rates. Your role is to provide the "Specialist Interview Checklist" to ensure your client is in the right hands.</p>

 <h2 id="lifestyle">Pain Management & Lifestyle Alignment</h2>
 <p>Chronic pain creates a state of <strong>central sensitization</strong>‚Äîwhere the nervous system becomes hyper-reactive. This impacts every facet of the client's life, particularly intimacy. Many clients feel "broken" or guilty for their lack of libido (dyspareunia).</p>

 <p>Coaching strategies for pelvic pain alignment:</p>
 <ul>
 <li><strong>Pelvic Floor Physical Therapy (PFPT):</strong> Mandatory referral for Stage III/IV cases to address secondary muscle guarding.</li>
 <li><strong>Somatic Tracking:</strong> Teaching the client to observe pain without the "danger" signal, reducing the cortisol spike associated with flare-ups.</li>
 <li><strong>Intimacy Reframing:</strong> Moving away from "goal-oriented" sex (which can be painful and stressful) toward "connection-oriented" intimacy during the healing phase.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Financial Value of Expertise</span>
 <p>üí° Clients with advanced endo/adeno are often the most underserved in the medical system. By mastering these complex cases, you move from a "generalist" to a "specialist." Specialists in this niche typically charge <strong>$3,000 - $5,000</strong> for 3-month intensive support packages.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 <div class="question-item">
 <p class="question-text"><strong>1. Why is excision surgery preferred over ablation for Stage III/IV Endometriosis?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Ablation only treats the surface of the lesion (like mowing weeds), leading to high recurrence rates. Excision removes the lesion entirely at the root, significantly reducing recurrence and improving the biochemical environment for conception.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>2. What is the "Junctional Zone" and why does it matter in Adenomyosis?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">The Junctional Zone (JZ) is the interface between the endometrium and myometrium. In adenomyosis, this zone thickens (often >12mm). A thickened JZ is associated with uterine hyper-contractility and significantly lower implantation rates.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>3. Which antioxidant has been specifically shown in clinical trials to reduce the size of endometriomas?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">N-Acetyl Cysteine (NAC). A 2013 study showed that 600mg 3x/day for 3 months led to a reduction in cyst size or even complete disappearance in half of the study group.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>4. How does the "estrogen-inflammation loop" work in endometriosis?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Endometriotic lesions contain the enzyme aromatase, which allows them to produce their own estrogen. This estrogen then fuels further inflammation, which in turn stimulates more aromatase activity, creating a self-perpetuating cycle of disease growth.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Advanced Endometriosis (Stage III/IV) is both a mechanical and a systemic inflammatory disease that compromises egg quality.</li>
 <li>Adenomyosis is a primary driver of "unexplained" implantation failure and often requires GnRH agonist suppression before embryo transfer.</li>
 <li>The Anti-Inflammatory Fertility Protocol (AIFP) must prioritize high-dose NAC, Curcumin, and strict dietary eliminations to be effective in complex cases.</li>
 <li>Surgical advocacy is a core coaching pillar; excision by a specialist is the gold standard for preserving fertility and reducing pain.</li>
 <li>Addressing the "Central Sensitization" of pain through PFPT and somatic tools is essential for restoring the client's quality of life and intimacy.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Porpora et al. (2013). "A promise in the treatment of endometriosis: an observational cohort study on ovarian endometrioma reduction by N-acetylcysteine." <em>Evidence-Based Complementary and Alternative Medicine.</em></li>
 <li>Harada et al. (2022). "The impact of adenomyosis on women's fertility." <em>Fertility and Sterility Reviews.</em></li>
 <li>Abrao et al. (2021). "Deep endometriosis: definition, diagnosis, and treatment." <em>Journal of Minimally Invasive Gynecology.</em></li>
 <li>Nezhat et al. (2020). "Endometriosis: Ancient Disease, Ancient Treatments." <em>Fertility and Sterility.</em></li>
 <li>Bulun et al. (2019). "Endometriosis." <em>New England Journal of Medicine.</em></li>
 <li>Garcia-Velasco et al. (2023). "Optimizing IVF outcomes in patients with severe endometriosis." <em>Reproductive BioMedicine Online.</em></li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });
</script>

</body>
</html>